GRANDAXIN 50mg tablets medication leaflet

N05BA23 tofisopam • Nervous system | Anxiolytics | Benzodiazepine derivatives

Tofisopam is a benzodiazepine-class medication used in the treatment of anxiety disorders and other stress-related conditions. Unlike other benzodiazepines, tofisopam has a unique profile, providing anxiolytic effects without significant sedation or dependency.

Tofisopam is administered orally, usually two or three times daily, with the dose adjusted based on the severity of symptoms and the patient's response. It is indicated for patients who require anxiety reduction without impairing cognitive or motor functions.

Common side effects include nausea, dizziness, headache, and gastric discomfort. In rare cases, severe adverse reactions such as allergic reactions or liver function impairment may occur. Regular monitoring of the patient's condition is essential during treatment.

Tofisopam is an effective and well-tolerated therapeutic option for managing anxiety, contributing to improved quality of life for patients.

General data about GRANDAXIN 50mg

Substance: tofisopam

Date of last drug list: 01-04-2014

Commercial code: W05938001

Concentration: 50mg

Pharmaceutical form: tablets

Quantity: 20

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).